Routine annual influenza immunization is increasingly recommended in young children. We
compared the safety and immunogenicity of vaccination with trivalent inactivated influenza …

Vaccines are some of the most effective tools for the prevention of infectious diseases.
Adjuvants are included in vaccines for a variety of reasons: to increase the breadth of …

Preparedness against an A/H5N1 influenza pandemic requires well-tolerated, effective
vaccines which provide both vaccine strain-specific and heterologous, cross-clade …

In accordance with European directives, each year the enhanced safety surveillance (ESS)
of seasonal influenza vaccines should be conducted in order to detect any potential …

We reviewed the safety of MF59-adjuvanted versus non-adjuvanted influenza vaccines in
children and adolescents (aged 6 months–18 years) in an integrated analysis of all pediatric …

Recent cases of avian influenza H7N9 have caused great concerns that virus may become
transmittable between humans. It is imperative to develop an effective vaccine to fight …

The first cases of pandemic influenza A (H1N1) 2009 infection were seen in Mexico in March
2009. Since then, it is thought to have been responsible for at least 18,337 deaths globally …

Introduction: Systemic lupus erythematosus (SLE) is a chronic systemic autoimmune
disease. In SLE, immune system dysfunction is postulated to result by virtue of the disease …

Background During development of an A/H1N1 pandemic influenza vaccine, this study was
performed to identify the antigen and adjuvant content which would provide optimal antibody …

OBJECTIVE: To assess the potential acute effects regarding the immunogenicity and safety
of non-adjuvanted influenza A H1N1/2009 vaccine in patients with mixed connective tissue …